Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Neoadjuvant Setting: Specifically, caution is advised for patients using GLP-1 RAs during neoadjuvant regimens like the phase 3 KEYNOTE-522 trial (NCT03036488)
Ferhatbegovi L et al
The additional GIP receptor activation appears to augment insulin secretion further, though the precise contribution of GIP agonism to clinical outcomes, including potential effects on fat metabolism and energy expenditure, remains an area of active investigation with limited human data
differentiation from pseudoseizure pseudoseizure (technical terminology varies, including Paroxysmal Non-Epileptic Seizures or psychogenic, non-epileptic attacks or functional seizures) A clinical phenomenon that mimics a seizure, often related to psychiatric stress
US$ 28.91
US$ 21.98
US$ 23.70
US$ 22.85
US$ 29.76
US$ 29.56
US$ 24.18
US$ 20.28
